Search clinical trials for: Hemic and Lymphatic Diseases

Total 482145 results

Sun Yat-sen University

Recruiting

Clinical Study of Radical Right Hemicolectomy Versus Radical Right Hemicolectomy Combined With Indocyanine Green Fluorescence Imaging Lymphatic Tracer Dissection for the Treatment of Right Colon Cancer

Colon Cancer

China
Haraldsplass Deaconess Hospital
University of Bergen; Helse-Bergen HF

Active, not recruiting

Open D3 Right Hemicolectomy Compared to Laparoscopic CME for Right Sided Colon Cancer (D3/CME)

Quality of Life | Complication | Surgical Procedure, Unspecified | Circulating Tumor Cell | Lymph Node Metastases

Norway
Shanghai Minimally Invasive Surgery Center

Active, not recruiting

Infrapyloric and Greater Curvature Lymph Node Metastasis in Colon Cancer

Colorectal Neoplasm

China
Gabriele Anania

Completed

Italian Study on the Right Hemicolectomy: How the Lymphadenectomy is Performed (CoDIG-2)

Colon Cancer | Surgical Procedure, Unspecified | Lymph Node Metastasis

Italy
Charite University, Berlin, Germany

Completed

Diagnostic Biomarkers for Adult Hemophagocytic Lymphohistiocytosis in Critically Ill Patients (HEMICU)

Hemophagocytic Lymphohistiocytosis

Germany
Children's Hospital Medical Center, Cincinnati
Amgen

Completed

Pilot Study of Etanercept (Enbrel) in Children With Fanconi Anemia

Fanconi Anemia

United States
The First Affiliated Hospital with Nanjing Medical...

Unknown

Laparoscopic Right Hemicoloectomy for Right Colon Cancer With a Medial-to-lateral Approach Orientated by SMA or SMV

Right Colic Lymphadenopathy

China
Novartis Pharmaceuticals

Completed

Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment.

Hodgkin Lymphoma

United States
Chengdu Zenitar Biomedical Technology Co., Ltd

Recruiting

A Phase IIa Clinical Study of Puesta Mesylate for Injection in Patients With T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

Cutaneous T-cell Lymphoma (CTCL) | Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

China
Malaghan Institute of Medical Research
Wellington Zhaotai Therapies Limited; BioOra Limited

Not yet recruiting

A Study of WZTL-002 CAR T-cells for Adults With Relapsed Large B-cell Lymphoma (ENABLE-2)

Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Large B-cell Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Transformed Non-Hodgkin Lymphoma

New Zealand
Yunnan Cancer Hospital
Affiliated Cancer Hospital of Shantou University Medical College

Not yet recruiting

Evaluation of Axillary Lymph Node Metastasis Status of Breast Cancer Based on Pathological Image and Virtual Staining

Breast Cancer | Lymph Node Metastasis | Digital Pathology | Virtual Staining
Axter Therapeutics (Beijing) Co., Ltd

Not yet recruiting

Study of AXT-1003 in Subjects With Advanced Malignant Tumors.

Non-Hodgkin Lymphoma | Advanced Solid Tumor

China
The First Affiliated Hospital of Soochow University

Not yet recruiting

CMOP±R in the Treatment of Untreated Non-Hodgkin's Lymphoma

NHL
University Health Network, Toronto
Myeloma Canada; The Leukemia and Lymphoma Society of Canada

Not yet recruiting

Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma

Lymphoma, B-Cell | Multiple Myeloma | B Cell Lymphoma | Multiple Myeloma in Relapse | Multiple Myeloma, Refractory | Multiple Myeloma Progression | Multiple Myeloma Stage III | Aggressive Lymphoma
Rita Assi

Not yet recruiting

A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL

B-cell Lymphoma | Refractory Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin Lymphoma | Relapsed Hodgkin Lymphoma

United States
Institute of Hematology & Blood Diseases Hospital...

Not yet recruiting

Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALL

Acute Lymphoblastic Leukemia, Adult | Philadelphia Chromosome Negative ALL

China
Institute of Hematology & Blood Diseases Hospital...

Not yet recruiting

Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL

Philadelphia Positive Acute Lymphoblastic Leukemia | Acute Lymphoblastic Leukemia, Adult

China
MTI University

Recruiting

PMR Versus MLD on RLS and Sleep Quality in Hemodialysis Patients

Hemodialysis Complication

Egypt
Chinese PLA General Hospital
Peking University; EdiGene Inc.

Recruiting

TCR Reserved and Power3 Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALL

Acute Lymphocytic Leukemia

China
Christian Schmidt, MD
Johannes Gutenberg University Mainz

Recruiting

CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma (CARMAN)

Mantle Cell Lymphoma

Germany
Peking Union Medical College Hospital

Recruiting

Glofitamab in Chinese Patients With R/R DLBCL

DLBCL - Diffuse Large B Cell Lymphoma

China
Shanghai Ming Ju Biotechnology Co., Ltd.

Not yet recruiting

CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma

Non-Hodgkin Lymphoma | Large B-cell Lymphoma

China
The First Affiliated Hospital of Xiamen University
Fujian Cancer Hospital; Chinese PLA General Hospital; Jiangxi Provincial Cancer... and other collaborators

Recruiting

Prospective Clinical Study of Obrutinib in Combination With Rituximab (OR) for Primary Marginal Zone Lymphoma (MZL) That Failed or Not Suitable for Local Therapy

Marginal Zone Lymphoma

China
Henan Cancer Hospital

Recruiting

L218CAR19 in Patients With Relapsed/Refractory B-cell Lymphoma

Relapsed/Refractory B-cell Lymphomas

China
St. Petersburg State Pavlov Medical University

Recruiting

BeFluBu vs FluBuRux Conditioning in Haploidentical HCT

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Lymphoblastic Lymphoma | Myeloproliferative Neoplasm | Biphenotypic Acute Leukemia

Russian Federation
Queensland Centre for Gynaecological Cancer
Royal Brisbane and Women's Hospital

Not yet recruiting

Australian National Vulvar Cancer Trial (ANVU)

Ultrasound Therapy; Complications | Lymph Node Metastasis | Groin Node | Vulvar Cancer Stage II | Vulvar Cancer Stage I

Australia
Federal Research Institute of Pediatric Hematology...

Recruiting

Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Malignant Lymphoma | Biphenotypic Acute Leukemia

Russian Federation
Pfizer

Not yet recruiting

A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.

Acute Lymphocytic Leukemia
CHU de Reims

Recruiting

Description of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious Risk

Chronic Lymphocytic Leukemia

France
Dana-Farber Cancer Institute
Merck Sharp & Dohme LLC

Not yet recruiting

Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL

Lymphoma | Primary Central Nervous System Lymphoma

United States
Tianjin Medical University Cancer Institute and...

Not yet recruiting

Zanubrutinib and G-CHOP in Untreated Intermediate-high Risk Follicular Lymphoma

FL
Soligenix

Not yet recruiting

Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL (FLASH2)

Mycosis Fungoides | Cutaneous T Cell Lymphoma | CTCL | CTCL/ Mycosis Fungoides
Chinese PLA General Hospital

Recruiting

A Phase ll Trial of the Combination of Zanubrutinib, Rituximab and Venetoclax in Patients With Previously Untreated Follicular Lymphoma (ZARAV)

Ann Arbor Stage II Follicular Lymphoma | Ann Arbor Stage III Follicular Lymphoma | Ann Arbor Stage IV Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma

China
Janssen Research & Development, LLC

Recruiting

A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Lymphoma, Non-Hodgkin | Relapsed B-cell NHL | Refractory B-Cell NHL

Turkey
Second Affiliated Hospital of Xi'an Jiaotong University

Recruiting

Improvements in Thyroid Tumor Surgery and the Prognosis, Diagnosis, Recurrence and Metastasis of Patients

Carcinogenesis | Papillary Thyroid Cancer | Lymph Node Metastasis

China
Xianmin Song, MD

Recruiting

Reduced Intensity Conditioning With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory Peripheral T-cell Lymphoma.

Peripheral T Cell Lymphoma

China
Kerry Rogers

Not yet recruiting

Pirtobrutinib (LOXO-305) and Venetoclax for the Treatment of Patients With CLL or SLL Resistant to Covalent BTKi

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Institute of Hematology & Blood Diseases Hospital...

Recruiting

A Prospective Clinical Study of CD3-CD20 Bisspecific Antibody Based Therapy Combined With CD19-CAR T Cells in the Treatment of Relapsed Refractory B-cell Non-Hodgkin Lymphoma

B-cell Non-Hodgkin Lymphoma

China
Second Affiliated Hospital, School of Medicine,...

Not yet recruiting

Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma (CD19-CARNK/T)

Mantle Cell Lymphoma (MCL) | Primary Mediastinal B-cell Lymphoma (PMBCL) | Diffuse Large B Cell Lymphoma( DLBCL)
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Not yet recruiting

A Study of IMM01 Plus Tiselizumab Versus Physician's Choice Chemotherapy in PD(L)1-refractory Classical Hodgkin Lymphoma

Classic Hodgkin Lymphoma
Tr1X, Inc.

Recruiting

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Myelodysplastic Syndromes | Hematologic Malignancy | Hematopoietic Stem Cell Transplant | Acute Myeloid Leukemia in Remission | GVHD, Chronic | GVHD,Acute | GvHD | Acute Lymphoblastic Leukemia, Adult B-Cell | Cancer Remission | Acute Lymphoblastic Leukemia, Adult T-Cell | Chronic Myelomonocytic Leukemia,...

United States
Chi Kong Li
Hong Kong Children's Hospital

Recruiting

Anti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) Therapy for Treatment of B-cell Hematological Malignancies

Leukemia, Lymphocytic | Lymphoma, Nonhodgkin

China
Institute of Hematology & Blood Diseases Hospital...

Not yet recruiting

the Efficacy and Safety of Total Myeloid Irradiation (TMI) in the Treatment of Adult Acute Lymphoblastic Leukemia (TMI)

Acute Lymphoblastic Leukemia
Koo Foundation Sun Yat-Sen Cancer Center

Recruiting

Ga-68-CXCR4 PET/CT in Indolent B-cell Lymphoma (PentixaFor)

Indolent B-Cell Non-Hodgkin Lymphoma

Taiwan
Abramson Cancer Center at Penn Medicine
Genmab

Not yet recruiting

Epcoritamab-CAR T Cells for Large B-cell Lymphomas

Lymphoma, Non-Hodgkin | High-grade B-cell Lymphoma | Refractory Diffuse Large B-cell Lymphoma | Relapsed Diffuse Large B Cell Lymphoma | Transformed Indolent Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma

United States
Ningbo No. 1 Hospital

Recruiting

First-line Treatment of PCNSL With the Combination of Orelabrutinib, Rituximab, and Methotrexate (ORM Regimen)

Primary Central Nervous System Lymphoma

China
Peking Union Medical College Hospital

Recruiting

Orelabrutinib Combined With Obinutuzumab and Lenalidomide (OGL Regimen) as First-line Treatment for Marginal Zone Lymphoma.

Marginal Zone Lymphoma

China
Seoul National University Hospital
Kangbuk Samsung Hospital; Korea University Ansan Hospital

Recruiting

Cohort Study for Gastric MALT Lymphoma (HUG-MALToma)

Gastric MALT Lymphoma

Korea, Republic of
Parc de Salut Mar

Recruiting

Shock Wave Therapy for Lower Limb Lymphedema

Lymphedema, Lower Limb

Spain
City of Hope Medical Center
National Cancer Institute (NCI)

Not yet recruiting

Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma

Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Refractory Grade 1 Follicular Lymphoma | Refractory Grade 2 Follicular Lymphoma | Refractory Grade 3a Follicular Lymphoma

United States

Search clinical trials for: Hemic and Lymphatic Diseases

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations